• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中的表观遗传失调:对基因表达和DNA修复相关通路的影响。

Epigenetic Dysregulation in Cancer: Implications for Gene Expression and DNA Repair-Associated Pathways.

作者信息

Rembiałkowska Nina, Rekiel Katarzyna, Urbanowicz Piotr, Mamala Mateusz, Marczuk Karolina, Wojtaszek Maria, Żywica Marta, Radzevičiūtė-Valčiukė Eivina, Novickij Vitalij, Kulbacka Julita

机构信息

Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, Poland.

Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland.

出版信息

Int J Mol Sci. 2025 Jul 7;26(13):6531. doi: 10.3390/ijms26136531.

DOI:10.3390/ijms26136531
PMID:40650308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12249909/
Abstract

Epigenetic modifications are heritable, reversible alterations that causally reshape chromatin architecture and thereby influence DNA repair without changing nucleotide sequence. DNA methylation, histone modifications and non-coding RNAs profoundly influence DNA repair mechanisms and genomic stability. Aberrant epigenetic patterns in cancer compromise DNA damage recognition and repair, therefore impairing homologous recombination (HR), non-homologous end joining (NHEJ), and base excision repair (BER) by suppressing key repair genes and lowering access to repair sites. Then it is dissected how loss-of-function mutations in Switch/Sucrose non-fermentable, imitation switch and CHD (Chromodomain helicase DNA-binding) chromatin-remodeling complexes impair nucleosome repositioning, preventing effective damage sensing and assembly of repair machinery. Non-coding RNAs contribute to epigenetic silencing at DNA break sites, exacerbating repair deficiencies. This review evaluates recent advances concerning epigenetic dysfunction and DNA repair impairment. It is also highlighted that nanoparticle-mediated delivery strategies are designed to overcome pharmacologic resistance. It is presented how epigenetic dysregulation of DNA repair can guide more effective and drug-resistant cancer therapies.

摘要

表观遗传修饰是可遗传的、可逆的改变,它通过重塑染色质结构从而在不改变核苷酸序列的情况下影响DNA修复。DNA甲基化、组蛋白修饰和非编码RNA对DNA修复机制和基因组稳定性有深远影响。癌症中异常的表观遗传模式会损害DNA损伤识别和修复,从而通过抑制关键修复基因并减少对修复位点的 access,损害同源重组(HR)、非同源末端连接(NHEJ)和碱基切除修复(BER)。接着剖析了Switch/Sucrose non-fermentable、imitation switch和CHD(染色质结构域解旋酶DNA结合)染色质重塑复合物中的功能丧失突变如何损害核小体重新定位,阻止有效的损伤感知和修复机制的组装。非编码RNA导致DNA断裂位点的表观遗传沉默,加剧修复缺陷。本综述评估了表观遗传功能障碍和DNA修复损伤的最新进展。还强调了纳米颗粒介导的递送策略旨在克服耐药性。展示了DNA修复的表观遗传失调如何指导更有效和抗耐药的癌症治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/12249909/19cd905a075d/ijms-26-06531-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/12249909/2b1d9caf9beb/ijms-26-06531-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/12249909/28aba644f204/ijms-26-06531-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/12249909/c80a09932733/ijms-26-06531-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/12249909/19cd905a075d/ijms-26-06531-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/12249909/2b1d9caf9beb/ijms-26-06531-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/12249909/28aba644f204/ijms-26-06531-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/12249909/c80a09932733/ijms-26-06531-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/12249909/19cd905a075d/ijms-26-06531-g004.jpg

相似文献

1
Epigenetic Dysregulation in Cancer: Implications for Gene Expression and DNA Repair-Associated Pathways.癌症中的表观遗传失调:对基因表达和DNA修复相关通路的影响。
Int J Mol Sci. 2025 Jul 7;26(13):6531. doi: 10.3390/ijms26136531.
2
An insight into understanding the coupling between homologous recombination mediated DNA repair and chromatin remodeling mechanisms in plant genome: an update.深入了解同源重组介导的 DNA 修复与植物基因组中染色质重塑机制的偶联:最新进展。
Cell Cycle. 2021 Sep;20(18):1760-1784. doi: 10.1080/15384101.2021.1966584. Epub 2021 Aug 26.
3
Exploring Epigenetic Complexity in Regulation of Hematopoietic Stem Cells Niche: A Mechanistic Journey from Normal to Malignant Hematopoiesis.探索造血干细胞微环境调控中的表观遗传复杂性:从正常造血到恶性造血的机制之旅。
Adv Exp Med Biol. 2025;1483:49-67. doi: 10.1007/5584_2024_846.
4
Epigenetic regulation of bone remodeling and bone metastasis.骨重塑与骨转移的表观遗传调控
Semin Cell Dev Biol. 2024 Feb 15;154(Pt C):275-285. doi: 10.1016/j.semcdb.2022.11.002. Epub 2022 Nov 12.
5
[Epigenetics' implication in autism spectrum disorders: A review].[表观遗传学在自闭症谱系障碍中的影响:综述]
Encephale. 2017 Aug;43(4):374-381. doi: 10.1016/j.encep.2016.07.007. Epub 2016 Sep 28.
6
Ubiquitin proteasome system (UPS): a crucial determinant of the epigenetic landscape in cancer.泛素蛋白酶体系统(UPS):癌症表观遗传格局的关键决定因素。
Epigenomics. 2025 Jun;17(9):625-644. doi: 10.1080/17501911.2025.2501524. Epub 2025 May 8.
7
Epigenetics in evolution and adaptation to environmental challenges: pathways for disease prevention and treatment.表观遗传学在进化及对环境挑战的适应中:疾病预防与治疗的途径
Epigenomics. 2025 Apr;17(5):317-333. doi: 10.1080/17501911.2025.2464529. Epub 2025 Feb 13.
8
The epigenetic potential of vitamin K2 in brain health.维生素K2在脑健康方面的表观遗传潜力。
Epigenomics. 2025 Jul;17(10):681-690. doi: 10.1080/17501911.2025.2518916. Epub 2025 Jun 12.
9
Epi-nutrients for cancer prevention: Molecular mechanisms and emerging insights.用于癌症预防的表型营养素:分子机制与新见解
Cell Biol Toxicol. 2025 Jul 15;41(1):116. doi: 10.1007/s10565-025-10054-2.
10
A systematic review of epigenetic interplay in kidney diseases: Crosstalk between long noncoding RNAs and methylation, acetylation of chromatin and histone.系统综述肾脏疾病中的表观遗传相互作用:长非编码 RNA 与染色质甲基化、乙酰化和组蛋白之间的串扰。
Biomed Pharmacother. 2024 Jul;176:116922. doi: 10.1016/j.biopha.2024.116922. Epub 2024 Jun 12.

本文引用的文献

1
Acute resistance to BET inhibitors remodels compensatory transcriptional programs via p300 coactivation.对BET抑制剂的急性抗性通过p300共激活重塑补偿性转录程序。
Blood. 2025 Feb 13;145(7):748-764. doi: 10.1182/blood.2022019306.
2
Acetylation of Histone H3 in Cancer Progression and Prognosis.组蛋白 H3 乙酰化在癌症进展和预后中的作用。
Int J Mol Sci. 2024 Oct 12;25(20):10982. doi: 10.3390/ijms252010982.
3
SMARCA2 and SMARCA4 Participate in DNA Damage Repair.SMARCA2 和 SMARCA4 参与 DNA 损伤修复。
Front Biosci (Landmark Ed). 2024 Jul 23;29(7):262. doi: 10.31083/j.fbl2907262.
4
DNA methylation in human diseases.人类疾病中的DNA甲基化
Heliyon. 2024 Jun 4;10(11):e32366. doi: 10.1016/j.heliyon.2024.e32366. eCollection 2024 Jun 15.
5
Beyond traditional translation: ncRNA derived peptides as modulators of tumor behaviors.超越传统翻译:ncRNA 衍生肽作为肿瘤行为调节剂。
J Biomed Sci. 2024 Jun 14;31(1):63. doi: 10.1186/s12929-024-01047-0.
6
RAPID resistance to BET inhibitors is mediated by FGFR1 in glioblastoma.胶质母细胞瘤中,FGFR1介导对BET抑制剂的快速耐药。
Sci Rep. 2024 Apr 23;14(1):9284. doi: 10.1038/s41598-024-60031-8.
7
H3K4me1 facilitates promoter-enhancer interactions and gene activation during embryonic stem cell differentiation.H3K4me1 促进胚胎干细胞分化过程中的启动子-增强子相互作用和基因激活。
Mol Cell. 2024 May 2;84(9):1742-1752.e5. doi: 10.1016/j.molcel.2024.02.030. Epub 2024 Mar 20.
8
Targeting KDM4 family epigenetically triggers antitumour immunity via enhancing tumour-intrinsic innate sensing and immunogenicity.靶向 KDM4 家族通过增强肿瘤内在固有感应和免疫原性来触发抗肿瘤免疫。
Clin Transl Med. 2024 Feb;14(2):e1598. doi: 10.1002/ctm2.1598.
9
The SWI/SNF Complex: A Frequently Mutated Chromatin Remodeling Complex in Cancer.SWI/SNF 复合物:癌症中经常发生突变的染色质重塑复合物。
Cancer Treat Res. 2023;190:211-244. doi: 10.1007/978-3-031-45654-1_7.
10
Epigenetic modifications: Key players in cancer heterogeneity and drug resistance.表观遗传修饰:癌症异质性和耐药性的关键因素
Transl Oncol. 2024 Jan;39:101821. doi: 10.1016/j.tranon.2023.101821. Epub 2023 Nov 4.